TEVA earnings
Teva Pharmaceutical Industries (TEVA) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- TEVA reports next on Jan 27, 2027, with EPS of 0.70 expected.
- TEVA beat EPS estimates in 13 of its last 17 reports.
TEVA earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 3, 2026 | 0.86 | 0.72 | 19.44% | $4.39B |
| Q2 2026 | Jul 29, 2026 | 0.02 | 0.08 | -75.00% | $4.14B |
| Q1 2026 | Apr 29, 2026 | 0.53 | 0.50 | 6.00% | $3.98B |
| Q4 2025 | Jan 28, 2026 | 0.96 | 0.65 | 47.69% | $4.71B |
| Q3 2025 | Nov 5, 2025 | 0.78 | 0.68 | 14.71% | $4.48B |
| Q2 2025 | Jul 30, 2025 | 0.66 | 0.63 | 4.76% | $4.18B |
| Q1 2025 | May 7, 2025 | 0.52 | 0.47 | 10.64% | $3.89B |
| Q4 2024 | Jan 29, 2025 | 0.71 | 0.69 | 2.90% | $4.23B |
| Q3 2024 | Nov 6, 2024 | 0.69 | 0.65 | 6.15% | $4.33B |
| Q2 2024 | Jul 31, 2024 | 0.61 | 0.57 | 7.02% | $4.16B |
| Q1 2024 | May 8, 2024 | 0.48 | 0.51 | -5.88% | $3.82B |
| Q4 2023 | Jan 31, 2024 | 1.00 | 0.75 | 33.33% | $4.46B |
| Q3 2023 | Nov 8, 2023 | 0.60 | 0.60 | 0.00% | $3.85B |
| Q2 2023 | Aug 2, 2023 | 0.56 | 0.54 | 3.70% | $3.88B |
| Q1 2023 | May 10, 2023 | 0.40 | 0.57 | -29.82% | $3.66B |
| Q4 2022 | Feb 8, 2023 | 0.71 | 0.68 | 4.41% | $3.88B |
| Q3 2022 | Nov 3, 2022 | 0.59 | 0.61 | -3.28% | $3.60B |